GLP-1s may reduce fracture risk in patients with obesity, type 2 diabetestranslating…

Results presented at the American Orthopaedic Foot & Ankle Society Annual Meeting showed GLP-1 receptor agonists were not associated with increased fracture risk in patients with obesity or type 2 diabetes.

Factuality

74/100

Political Bias

Left

Ownership

Healio (SLACK Incorporated)

Country

USA

Region

North America

Language

English

Keywords#GLP-1s#fracture risk#diabetes#glp-1#obesity

Read Original ↗